Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) — Capital Reinvestment Ratio
Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD) has a Capital Reinvestment Ratio of 0.63x as of December 2025, meaning it reinvests 1% of its operating cash flow (₫213.49 Billion) in capital expenditures (₫135.54 Billion). See Binh Dinh Pharmaceutical and Medical Equ net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Binh Dinh Pharmaceutical and Medical Equipment JSC Capital Reinvestment Ratio (2020–2025)
This chart tracks Binh Dinh Pharmaceutical and Medical Equipment JSC's Capital Reinvestment Ratio across 6 annual periods. Check DBD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC (2020–2025)
Year-by-year Capital Reinvestment Ratio for Binh Dinh Pharmaceutical and Medical Equipment JSC from 2020 to 2025. For live market cap and broader valuation context, see Binh Dinh Pharmaceutical and Medical Equ (DBD) total market value.
| Year | Reinvestment Ratio | Operating CF (VND) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.66x | ₫615.19 Billion | ₫408.57 Billion | ▲ +18.2% |
| 2024 | 0.56x | ₫264.73 Billion | ₫148.75 Billion | ▲ +23.6% |
| 2023 | 0.45x | ₫293.99 Billion | ₫133.69 Billion | ▼ -9.4% |
| 2022 | 0.50x | ₫165.01 Billion | ₫82.83 Billion | ▲ +8.0% |
| 2021 | 0.46x | ₫117.57 Billion | ₫54.64 Billion | ▲ +65.6% |
| 2020 | 0.28x | ₫212.91 Billion | ₫59.73 Billion | — |